Cargando…

A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer

The difficulty of early diagnosis and the development of drug resistance are two major barriers to the successful treatment of cancer. Autophagy plays a crucial role in several cellular functions, and its dysregulation is associated with both tumorigenesis and drug resistance. Unc-51-like kinase 1 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Yan, Lu, Liao, Ning, Wu, Wan-Qin, Shi, Jun-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073181/
https://www.ncbi.nlm.nih.gov/pubmed/32033142
http://dx.doi.org/10.3390/cancers12020352
_version_ 1783506578739036160
author Liu, Li
Yan, Lu
Liao, Ning
Wu, Wan-Qin
Shi, Jun-Ling
author_facet Liu, Li
Yan, Lu
Liao, Ning
Wu, Wan-Qin
Shi, Jun-Ling
author_sort Liu, Li
collection PubMed
description The difficulty of early diagnosis and the development of drug resistance are two major barriers to the successful treatment of cancer. Autophagy plays a crucial role in several cellular functions, and its dysregulation is associated with both tumorigenesis and drug resistance. Unc-51-like kinase 1 (ULK1) is a serine/threonine kinase that participates in the initiation of autophagy. Many studies have indicated that compounds that directly or indirectly target ULK1 could be used for tumor therapy. However, reports of the therapeutic effects of these compounds have come to conflicting conclusions. In this work, we reviewed recent studies related to the effects of ULK1 on the regulation of autophagy and the development of drug resistance in cancers, with the aim of clarifying the mechanistic underpinnings of this therapeutic target.
format Online
Article
Text
id pubmed-7073181
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70731812020-03-19 A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer Liu, Li Yan, Lu Liao, Ning Wu, Wan-Qin Shi, Jun-Ling Cancers (Basel) Review The difficulty of early diagnosis and the development of drug resistance are two major barriers to the successful treatment of cancer. Autophagy plays a crucial role in several cellular functions, and its dysregulation is associated with both tumorigenesis and drug resistance. Unc-51-like kinase 1 (ULK1) is a serine/threonine kinase that participates in the initiation of autophagy. Many studies have indicated that compounds that directly or indirectly target ULK1 could be used for tumor therapy. However, reports of the therapeutic effects of these compounds have come to conflicting conclusions. In this work, we reviewed recent studies related to the effects of ULK1 on the regulation of autophagy and the development of drug resistance in cancers, with the aim of clarifying the mechanistic underpinnings of this therapeutic target. MDPI 2020-02-04 /pmc/articles/PMC7073181/ /pubmed/32033142 http://dx.doi.org/10.3390/cancers12020352 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liu, Li
Yan, Lu
Liao, Ning
Wu, Wan-Qin
Shi, Jun-Ling
A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title_full A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title_fullStr A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title_full_unstemmed A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title_short A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer
title_sort review of ulk1-mediated autophagy in drug resistance of cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073181/
https://www.ncbi.nlm.nih.gov/pubmed/32033142
http://dx.doi.org/10.3390/cancers12020352
work_keys_str_mv AT liuli areviewofulk1mediatedautophagyindrugresistanceofcancer
AT yanlu areviewofulk1mediatedautophagyindrugresistanceofcancer
AT liaoning areviewofulk1mediatedautophagyindrugresistanceofcancer
AT wuwanqin areviewofulk1mediatedautophagyindrugresistanceofcancer
AT shijunling areviewofulk1mediatedautophagyindrugresistanceofcancer
AT liuli reviewofulk1mediatedautophagyindrugresistanceofcancer
AT yanlu reviewofulk1mediatedautophagyindrugresistanceofcancer
AT liaoning reviewofulk1mediatedautophagyindrugresistanceofcancer
AT wuwanqin reviewofulk1mediatedautophagyindrugresistanceofcancer
AT shijunling reviewofulk1mediatedautophagyindrugresistanceofcancer